+ Site Statistics
+ Search Articles
+ Subscribe to Site Feeds
Most Shared
PDF Full Text
+ PDF Full Text
Request PDF Full Text
+ Follow Us
Follow on Facebook
Follow on Twitter
Follow on LinkedIn
+ Translate
+ Recently Requested

Synthesis and Characterization of a Highly Potent and Selective Isotopically Labeled Retinoic Acid Receptor Ligand, ALRT1550

Synthesis and Characterization of a Highly Potent and Selective Isotopically Labeled Retinoic Acid Receptor Ligand, ALRT1550

Journal of Organic Chemistry 63(3): 543-550

The syntheses of two labeled homologues of (2E,4E,6E)-7-(3,5-di-tert-butylphenyl)-3-methylocta-2,4,6-trienoic acid (ALRT1550, 2), [(13)CD(3)]ALRT1550 (3) and [(3)H]ALRT1550 (4), are described in this report. ALRT1550 is an exceptionally potent antiproliferative agent which is currently in phase I/II clinical trials for acute chemotherapy. Both homologues were prepared from commercially available 3,5-di-tert-butylbenzoic acid. Homologue [(13)CD(3)]ALRT1550 was labeled at the 7-position of the trienoic acid chain via addition of [(13)CD(3)]MgI to a Weinreb amide precursor. The preparation of [(3)H]ALRT1550 utilized novel methodology to synthesize a sterically hindered and site-specific tritium-labeled tert-butyl group. Saturation binding and Scatchard analysis of this ligand at the retinoic acid receptors are also described, along with competition binding (K(i)) values for a series of known retinoids using [(3)H]ALRT1550 or [(3)H]ATRA as the labeled probes.

(PDF emailed within 1 workday: $29.90)

Accession: 047509900

Download citation: RISBibTeXText

PMID: 11672043

Related references

Syntheses of isotopically labeled 4-(1-(3,5,5,8,8-pentamethyl-5,6,7,8-tetrahydro-2-naphthyl)ethenyl)benzoic acid (LGD1069), a potent retinoid X receptor-selective ligand. Journal of Labelled Compounds and Radiopharmaceuticals 36(7): 701-712, 1995

A novel retinoic acid receptor-selective retinoid, ALRT1550, has potent antitumor activity against human oral squamous carcinoma xenografts in nude mice. Cancer Research 57(1): 162-168, 1997

A new approach to receptor ligand design synthesis and conformation of a new class of potent and highly selective mu opioid antagonists utilizing tetrahydroisoquinoline carboxylic acid. Tetrahedron 44(3): 697-710, 1988

Identification of highly potent retinoic acid receptor alpha-selective antagonists. Journal of Medicinal Chemistry 40(16): 2445-2451, 1997

Synthesis and characterization of a highly potent and effective antagonist of retinoic acid receptors. Journal of Medicinal Chemistry 38(24): 4764-4767, 1995

Guanidine-acylguanidine bioisosteric approach in the design of radioligands: synthesis of a tritium-labeled N(G)-propionylargininamide ([3H]-UR-MK114) as a highly potent and selective neuropeptide Y Y1 receptor antagonist. Journal of Medicinal Chemistry 51(24): 8168-8172, 2008

Discovery of KRP-199 Synthesis of novel quinoxalinecarboxylic acid derivatives as highly potent and selective AMPA receptor antagonists. Abstracts of Papers American Chemical Society 223(1-2): MEDI 42, 2002

Arginine of retinoic acid receptor beta which coordinates with the carboxyl group of retinoic acid functions independent of the amino acid residues responsible for retinoic acid receptor subtype ligand specificity. Archives of Biochemistry and Biophysics 409(2): 375-384, 2002

Synthesis and pharmacological evaluations of gamma-carboxylic acid bioisosteres of SYM 2081, a potent and selective kainate receptor ligand. Abstracts of Papers American Chemical Society 210(1-2): MEDI 149, 1995

Synthesis and Pharmacological Characterization of C4-(Thiotriazolyl)-substituted-2-aminobicyclo[3.1.0]hexane-2,6-dicarboxylates. Identification of (1R,2S,4R,5R,6R)-2-Amino-4-(1H-1,2,4-triazol-3-ylsulfanyl)bicyclo[3.1.0]hexane-2,6-dicarboxylic Acid (LY2812223), a Highly Potent, Functionally Selective mGlu2 Receptor Agonist. Journal of Medicinal Chemistry 58(18): 7526-7548, 2015

RBI-257: A highly potent dopamine D-4 receptor-selective ligand. European Journal of Pharmacology 331(2-3): 333-336, 1997

A simple synthesis of tritiated NPC 18166, a highly potent and selective 5HT-2 ligand. Abstracts of Papers American Chemical Society 208(1-2): MEDI 182, 1994

Synergistic activation of retinoic acid -responsive genes and induction of embryonal carcinoma cell differentiation by an RA receptor alpha -, RAR-beta-, or RAR-gamma-selective ligand in combination with a retinoid X receptor-specific ligand. Molecular & Cellular Biology 15(12): 6481-6487, 1995

Purification and functional characterization of the ligand-binding domain from the retinoic acid receptor a: evidence that sulfhydryl groups are involved in ligand-receptor interactions. Biochemistry (American Chemical Society) 32: 428-36, 1993